Steris
About: Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Employees: 17,787
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
123% more first-time investments, than exits
New positions opened: 116 | Existing positions closed: 52
88% more call options, than puts
Call options by funds: $57.7M | Put options by funds: $30.7M
29% more repeat investments, than reductions
Existing positions increased: 334 | Existing positions reduced: 259
25% more funds holding in top 10
Funds holding in top 10: 4 [Q1] → 5 (+1) [Q2]
7% more funds holding
Funds holding: 768 [Q1] → 824 (+56) [Q2]
6% more capital invested
Capital invested by funds: $20.8B [Q1] → $22.1B (+$1.34B) [Q2]
0.3% more ownership
Funds ownership: 93.51% [Q1] → 93.81% (+0.3%) [Q2]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
|
Morgan Stanley
Patrick Wood
|
$295
|
Overweight
Maintained
|
8 Aug 2025 |
|
Keybanc
Brett Fishbin
|
$288
|
Overweight
Maintained
|
22 Jul 2025 |
Financial journalist opinion
Based on 3 articles about STE published over the past 30 days
